United Therapeutics
UTHR
UTHR
320 hedge funds and large institutions have $3.27B invested in United Therapeutics in 2019 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 94 increasing their positions, 131 reducing their positions, and 105 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
320
Holders Change
-58
Holders Change %
-15.34%
% of All Funds
6.96%
Holding in Top 10
3
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-57.14%
% of All Funds
0.07%
New
54
Increased
94
Reduced
131
Closed
105
Calls
$27.3M
Puts
$34.7M
Net Calls
-$7.42M
Net Calls Change
+$16.4M
Top Buyers
| 1 |
Millennium Management
New York
|
+$129M |
| 2 |
Renaissance Technologies
New York
|
+$62.4M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$53.3M |
| 4 |
Two Sigma Investments
New York
|
+$45.4M |
| 5 |
D.E. Shaw & Co
New York
|
+$43.6M |
Top Sellers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$105M |
| 2 |
APG Asset Management
Amsterdam,
Netherlands
|
-$48.6M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$44.6M |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$39.3M |
| 5 |
BlackRock
New York
|
-$39.2M |
